Targeting HER-2 over expressed breast cancer cells with 2-cyclohexyl-N-[(Z)-(substituted phenyl/furan-2-yl/thiophene-2-yl)methylidene]hydrazinecarbothioamide

被引：15

作者：

Bhat, Mashooq Ahmad ^{[1
]}

Al-Dhfyan, Abdullah ^{[2
,3
]}

Khan, Azmat Ali ^{[1
]}

Al-Harbi, Nouf ^{[2
]}

Manogaran, P. S. ^{[2
]}

Alanazi, Amer M. ^{[1
]}

Fun, Hoong-Kun ^{[1
,4
]}

Al-Omar, Mohamed A. ^{[1
]}

机构：

[1] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh 11451, Saudi Arabia

[2] King Faisal Specialized Hosp & Res Ctr, Stem Cell & Tissue Re Engn Program, Res Ctr, Riyadh 11211, Saudi Arabia

[3] King Saud Univ, Dept Pharmacol & Toxicol, Coll Pharm, Riyadh 11451, Saudi Arabia

[4] Univ Sains Malaysia, Sch Phys, X Ray Crystallog Unit, Usm Penang 11800, Malaysia

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2015年 / 25卷 / 01期

关键词：

Thiosemicarbazones; Antitumor activity; Breast cancer; HER-2; (2Z)-N-CYCLOHEXYL-2-(3-HYDROXYBENZYLIDINE) HYDRAZINE CARBOTHIOAMIDE; STEM-CELLS; 338.15; K; RESISTANCE; LINES; THIOSEMICARBAZONES; IDENTIFICATION; CHEMOTHERAPY; SOLUBILITY; INHIBITORS;

D O I：

10.1016/j.bmcl.2014.11.009

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Cyclohexyl thiosemicarbazone derivatives (C1-14) were synthesized, characterized and evaluated against HER-2 over expressed breast cancer cells. The synthesized compounds were screened in vitro against four breast cancer cell lines; SKBr-3, MCF-7, MDA-MB-468 and MDA-MB-231. All the compounds showed activity against HER-2 over expressed SKBr-3 cells with (IC50 = 25.6 +/- 0.07 mu M-61.6 +/- 0.4 mu M). The most active compounds inhibit ALDH(+) breast cancer stem cells more effectively than the cancer stem cells specific agent Salinomycin. Immunohistochemistry staining also confirmed that these compounds inhibit the expression of HER-2 on SKBr-3 cells. Compound C2 significantly inhibited the cell migration and cell adhesion of breast cancer cell lines. Compound C2 was found to most active compound of this series targeting HER-2 over expressed breast cancer cells. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：83 / 87

页数：5

共 24 条

[21] HUMAN-BREAST CANCER - CORRELATION OF RELAPSE AND SURVIVAL WITH AMPLIFICATION OF THE HER-2 NEU ONCOGENE
SLAMON, DJ
CLARK, GM
WONG, SG
LEVIN, WJ
ULLRICH, A
MCGUIRE, WL
[J]. SCIENCE, 1987, 235 (4785) : 177 - 182
[22] Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tanei, Tomonori
Morimoto, Koji
Shimazu, Kenzo
Kim, Seung Jin
Tanji, Yoshio
Taguchi, Tetsuya
Tamaki, Yasuhiro
Noguchi, Shinzaburo
[J]. CLINICAL CANCER RESEARCH, 2009, 15 (12) : 4234 - 4241
[23] Discovery of N-(2,6-dimethylphenyl)-substituted semicarbazones as anticonvulsants:: Hybrid pharmacophore-based design
Yogeeswari, P
Sriram, D
Thirumurugan, R
Raghavendran, JV
Sudhan, K
Pavana, RK
Stables, J
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (20) : 6202 - 6211
[24] Iet-7 regulates self renewal and tumorigenicity of breast cancer cells
Yu, Fengyan
Yao, Herui
Zhu, Pengcheng
Zhang, Xiaoqin
Pan, Qiuhui
Gong, Chang
Huang, Yijun
Hu, Xiaoqu
Su, Fengxi
Lieberman, Judy
Song, Erwei
[J]. CELL, 2007, 131 (06) : 1109 - 1123

← 1 2 3 →